American International Group’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,628
| Closed | -$128K | – | 2484 |
|
|
2024
Q1 | $128K | Sell |
3,628
-33
| -0.9% | -$884 | ﹤0.01% | 2376 |
|
|
2023
Q4 | $108K | Sell |
3,661
-182
| -5% | -$3.78K | ﹤0.01% | 2518 |
|
|
2023
Q3 | $79.8K | Sell |
3,843
-408
| -10% | -$11.2K | ﹤0.01% | 2633 |
|
|
2023
Q2 | $104K | Sell |
4,251
-748
| -15% | -$24.1K | ﹤0.01% | 2549 |
|
|
2023
Q1 | $203K | Sell |
4,999
-95,439
| -95% | -$3.95M | ﹤0.01% | 2098 |
|
|
2022
Q4 | $4.51M | Sell |
100,438
-1,211
| -1% | -$54.8K | 0.03% | 741 |
|
|
2022
Q3 | $4.86M | Sell |
101,649
-4,335
| -4% | -$238K | 0.04% | 673 |
|
|
2022
Q2 | $6.27M | Sell |
105,984
-2,123
| -2% | -$174K | 0.04% | 602 |
|
|
2022
Q1 | $12.6M | Buy |
108,107
+202
| +0.2% | +$23.6K | 0.07% | 326 |
|
|
2021
Q4 | $16.2M | Sell |
107,905
-1,111
| -1% | -$150K | 0.08% | 246 |
|
|
2021
Q3 | $13M | Buy |
109,016
+107,758
| +8,566% | +$11.9M | 0.07% | 323 |
|
|
2021
Q2 | $123 | Sell |
1,258
-30
| -2% | -$2.67K | ﹤0.01% | 2794 |
|
|
2021
Q1 | $114 | Sell |
1,288
-151
| -10% | -$14K | ﹤0.01% | 2649 |
|
|
2020
Q4 | $138 | Sell |
1,439
-26
| -2% | -$2.68K | ﹤0.01% | 2483 |
|
|
2020
Q3 | $166K | Sell |
1,465
-43
| -3% | -$4.52K | ﹤0.01% | 2242 |
|
|
2020
Q2 | $149K | Sell |
1,508
-31,681
| -95% | -$2.53M | ﹤0.01% | 2296 |
|
|
2020
Q1 | $2.14M | Sell |
33,189
-1,917
| -5% | -$134K | 0.01% | 851 |
|
|
2019
Q4 | $2.09M | Sell |
35,106
-296
| -0.8% | -$18.3K | 0.01% | 978 |
|
|
2019
Q3 | $2.09M | Buy |
35,402
+110
| +0.3% | +$7.02K | 0.01% | 962 |
|
|
2019
Q2 | $2.28M | Buy |
35,292
+2,775
| +9% | +$179K | 0.01% | 953 |
|
|
2019
Q1 | $2.06M | Sell |
32,517
-1,053
| -3% | -$55.3K | 0.01% | 988 |
|
|
2018
Q4 | $1.27M | Sell |
33,570
-258
| -0.8% | -$9.11K | 0.01% | 1143 |
|
|
2018
Q3 | $1.45M | Buy |
33,828
+4,763
| +16% | +$166K | ﹤0.01% | 1217 |
|
|
2018
Q2 | $640K | Buy |
+29,065
| New | +$357K | ﹤0.01% | 1670 |
|
|
2017
Q2 | – | Sell |
-1,145
| Closed | -$14K | – | 3115 |
|
|
2017
Q1 | $14K | Buy |
1,145
+76
| +7% | +$1.66K | ﹤0.01% | 2972 |
|
|
2016
Q4 | $23K | Sell |
1,069
-3
| -0.3% | -$115 | ﹤0.01% | 2959 |
|
|
2016
Q3 | $82.1K | Buy |
1,072
+1
| +0.1% | +$73 | ﹤0.01% | 2721 |
|
|
2016
Q2 | $80.7K | Buy |
1,071
+36
| +3% | +$2.9K | ﹤0.01% | 2758 |
|
|
2016
Q1 | $90K | Hold |
1,035
| – | – | ﹤0.01% | 3502 |
|
|
2015
Q4 | $122K | Sell |
1,035
-2
| -0.2% | -$198 | ﹤0.01% | 3327 |
|
|
2015
Q3 | $91K | Buy |
1,037
+2
| +0.2% | +$233 | ﹤0.01% | 3564 |
|
|
2015
Q2 | $112K | Buy |
1,035
+508
| +96% | +$63.2K | ﹤0.01% | 3588 |
|
|
2015
Q1 | $66.5K | Hold |
527
| – | – | ﹤0.01% | 3816 |
|
|
2014
Q4 | $66.9K | Sell |
527
-21
| -4% | -$2.91K | ﹤0.01% | 3834 |
|
|
2014
Q3 | $73.5K | Hold |
548
| – | – | ﹤0.01% | 3778 |
|
|
2014
Q2 | $89.2K | Sell |
548
-78
| -12% | -$13.3K | ﹤0.01% | 3669 |
|
|
2014
Q1 | $138K | Buy |
626
+15
| +2% | +$3.83K | ﹤0.01% | 3177 |
|
|
2013
Q4 | $157K | Buy |
+611
| New | +$140K | ﹤0.01% | 2978 |
|
Other funds holding TNDM
ACH
FAM
CIP
BG
American International Group's TNDM Position: Q2 2024 in Review
American International Group sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 3,628 shares — an estimated $128K sold.
American International Group first reported a position in TNDM in Q4 2013 and held it in 38 quarters. The position peaked at $16.2M in Q4 2021. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.
- American International Group reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
- American International Group sold 3,628 Tandem Diabetes Care shares in Q2 2024, an estimated $128K.
- American International Group first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 38 quarters.
- American International Group's Tandem Diabetes Care position peaked at $16.2M in Q4 2021.
- 317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.